Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT05755958

Evaluation of the Efficacy of HIFU Treatment on Rectal Endometriosis Symptoms.

Doubled Blind Evaluation of the Efficacy of High Intensity Focused Ultrasound (HIFU) Treatment on Symptoms in Patients Treated for Rectal Endometriosis Compared to Sham.

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
60 (actual)
Sponsor
EDAP TMS S.A. · Industry
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

Rectal endometriosis (RE) induces lesions associated with painful symptoms that can alter quality of life. High Intensity Focused Ultrasound (HIFU) is a non-invasive ablative procedure using a high-intensity ultrasound probe to induce tissue devitalization using acoustic cavitation and thermal ablation. Focal One® is a transrectal HIFU device, which is validated to treat prostatic cancer. In this comparative, randomized, double blind study , the primary objective is to evaluate the efficacy of the HIFU treatment of rectal endometriosis with Focal One® HIFU device on the Acute Pelvic Pain 3 months after HIFU treatment, in comparison to a Sham group.

Conditions

Interventions

TypeNameDescription
DEVICEHIFU treatment in rectal EndometriosisHIFU treatment of rectal endometriosis
DEVICESHAM HIFU procedureSHAM HIFU procedure

Timeline

Start date
2023-02-03
Primary completion
2024-01-23
Completion
2025-07-31
First posted
2023-03-06
Last updated
2025-06-05

Locations

9 sites across 1 country: France

Source: ClinicalTrials.gov record NCT05755958. Inclusion in this directory is not an endorsement.